UiPath (PATH) 10-Q 4 Dec 23 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2023	Dec. 01, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		483,625,511
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 1,003,080	$ 1,402,119
Restricted cash	444	0
Marketable securities	814,097	354,774
Accounts receivable, net of allowance for credit losses of $1,023 and $2,698, respectively	373,091	374,217
Contract assets	84,164	69,260
Deferred contract acquisition costs	63,553	49,887
Prepaid expenses and other current assets	91,224	94,150
Total current assets	2,429,653	2,344,407
Marketable securities, non-current	0	2,942
Contract assets, non-current	6,078	6,523
Deferred contract acquisition costs, non-current	139,932	137,616
Property and equipment, net	22,504	29,045
Operating lease right-of-use assets	53,711	52,052
Intangible assets, net	16,460	23,010
Goodwill	87,293	88,010
Deferred tax assets	5,143	5,895
Other assets, non-current	26,284	45,706
Total assets	2,787,058	2,735,206
Current liabilities
Accounts payable	13,664	8,891
Accrued expenses and other current liabilities	108,014	76,645
Accrued compensation and employee benefits	100,170	142,582
Deferred revenue	405,837	398,334
Total current liabilities	627,685	626,452
Deferred revenue, non-current	132,600	121,697
Operating lease liabilities, non-current	57,687	56,442
Other liabilities, non-current	7,873	10,457
Total liabilities	825,845	815,048
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	0	0
Treasury stock, at cost, 3,239 shares and none, respectively	(52,649)	0
Additional paid-in capital	3,958,795	3,736,838
Accumulated other comprehensive income	3,158	7,612
Accumulated deficit	(1,948,097)	(1,824,298)
Total stockholders’ equity	1,961,213	1,920,158
Total liabilities and stockholders’ equity	2,787,058	2,735,206
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Accounts receivable, allowance for doubtful accounts	$ 1,023	$ 2,698
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock, at cost (in shares)	3,239	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	488,021	474,160
Common stock, shares outstanding (in shares)	484,782	474,160
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue:
Total revenue	$ 325,921	$ 262,744	$ 902,819	$ 750,032
Cost of revenue:
Total cost of revenue	49,920	42,768	142,574	132,360
Gross profit	276,001	219,976	760,245	617,672
Operating expenses:
Sales and marketing	191,282	156,469	521,413	527,798
Research and development	84,514	67,341	246,462	203,880
General and administrative	56,024	63,157	172,185	189,130
Total operating expenses	331,820	286,967	940,060	920,808
Operating loss	(55,819)	(66,991)	(179,815)	(303,136)
Interest income	14,483	9,561	41,913	15,057
Other income (expense), net	13,725	888	25,491	(2,523)
Loss before income taxes	(27,611)	(56,542)	(112,411)	(290,602)
Provision for income taxes	3,926	1,182	11,388	10,061
Net loss	$ (31,537)	$ (57,724)	$ (123,799)	$ (300,663)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.10)	$ (0.22)	$ (0.55)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.10)	$ (0.22)	$ (0.55)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	567,036	550,164	562,651	546,087
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	567,036	550,164	562,651	546,087
Licenses
Revenue:
Total revenue	$ 148,068	$ 118,175	$ 401,407	$ 338,875
Cost of revenue:
Total cost of revenue	2,781	3,208	8,336	7,915
Subscription services
Revenue:
Total revenue	167,529	130,159	473,880	370,309
Cost of revenue:
Total cost of revenue	28,647	20,578	78,502	63,949
Professional services and other
Revenue:
Total revenue	10,324	14,410	27,532	40,848
Cost of revenue:
Total cost of revenue	$ 18,492	$ 18,982	$ 55,736	$ 60,496

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (31,537)	$ (57,724)	$ (123,799)	$ (300,663)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	277	(324)	259	(625)
Foreign currency translation adjustments	(8,625)	(3,873)	(4,713)	(3,321)
Other comprehensive loss, net	(8,348)	(4,197)	(4,454)	(3,946)
Comprehensive loss	$ (39,885)	$ (61,921)	$ (128,253)	$ (304,609)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022				458,773	82,453
Beginning balance at Jan. 31, 2022	$ 1,921,917			$ 4	$ 1		$ 3,406,959	$ 10,899	$ (1,495,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,283
Issuance of common stock upon exercise of stock options	2,683						2,683
Vesting of early exercised stock options	1,355						1,355
Issuance of common stock upon settlement of restricted stock units (in shares)				3,499
Tax withholdings on settlement of restricted stock units (in shares)				(1,125)
Tax withholdings on settlement of restricted stock units	(24,827)						(24,827)
Stock-based compensation	102,085						102,085
Other comprehensive income (loss), net	(458)							(458)
Net loss	(122,561)								(122,561)
Ending balance (in shares) at Apr. 30, 2022				462,430	82,453
Ending balance at Apr. 30, 2022	1,880,194			$ 4	$ 1		3,488,255	10,441	(1,618,507)
Beginning balance (in shares) at Jan. 31, 2022				458,773	82,453
Beginning balance at Jan. 31, 2022	1,921,917			$ 4	$ 1		3,406,959	10,899	(1,495,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss), net	(3,946)
Net loss	(300,663)	$ (255,266)	$ (45,397)
Ending balance (in shares) at Oct. 31, 2022				469,924	82,453
Ending balance at Oct. 31, 2022	1,859,824			$ 5	$ 1		3,649,474	6,953	(1,796,609)
Beginning balance (in shares) at Apr. 30, 2022				462,430	82,453
Beginning balance at Apr. 30, 2022	1,880,194			$ 4	$ 1		3,488,255	10,441	(1,618,507)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,418
Issuance of common stock upon exercise of stock options	1,878						1,878
Issuance of common stock upon settlement of restricted stock units (in shares)				3,183
Issuance of common stock upon settlement of restricted stock units	1			$ 1
Tax withholdings on settlement of restricted stock units (in shares)				(1,040)
Tax withholdings on settlement of restricted stock units	(18,922)						(18,922)
Charitable donation of Class A common stock (in shares)				300
Charitable donation of Class A common stock	5,499						5,499
Shares issued in connection with business acquisition (in shares)				570
Shares issued in connection with business acquisition	2,965						2,965
Issuance of common stock under employee stock purchase plan (in shares)				578
Issuance of common stock under employee stock purchase plan	9,070						9,070
Repurchase of unvested early exercised stock options (in shares)				(441)
Stock-based compensation	88,533						88,533
Other comprehensive income (loss), net	709							709
Net loss	(120,378)								(120,378)
Ending balance (in shares) at Jul. 31, 2022				466,998	82,453
Ending balance at Jul. 31, 2022	1,849,549			$ 5	$ 1		3,577,278	11,150	(1,738,885)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,087
Issuance of common stock upon exercise of stock options	2,889						2,889
Issuance of common stock upon settlement of restricted stock units (in shares)				2,790
Tax withholdings on settlement of restricted stock units (in shares)				(951)
Tax withholdings on settlement of restricted stock units	(11,998)						(11,998)
Stock-based compensation	81,305						81,305
Other comprehensive income (loss), net	(4,197)							(4,197)
Net loss	(57,724)	$ (49,073)	$ (8,651)						(57,724)
Ending balance (in shares) at Oct. 31, 2022				469,924	82,453
Ending balance at Oct. 31, 2022	1,859,824			$ 5	$ 1		3,649,474	6,953	(1,796,609)
Beginning balance (in shares) at Jan. 31, 2023		474,160	82,453	474,160	82,453
Beginning balance at Jan. 31, 2023	1,920,158			$ 5	$ 1		3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				898
Issuance of common stock upon exercise of stock options	1,175						1,175
Issuance of common stock upon settlement of restricted stock units (in shares)				4,246
Tax withholdings on settlement of restricted stock units (in shares)				(1,463)
Tax withholdings on settlement of restricted stock units	(25,697)						(25,697)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215						4,215
Stock-based compensation	85,125						85,125
Other comprehensive income (loss), net	2,462							2,462
Net loss	(31,901)								(31,901)
Ending balance (in shares) at Apr. 30, 2023				478,122	82,453
Ending balance at Apr. 30, 2023	1,955,537			$ 5	$ 1		3,801,656	10,074	(1,856,199)
Beginning balance (in shares) at Jan. 31, 2023		474,160	82,453	474,160	82,453
Beginning balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1		3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	3,559
Repurchase of Class A common stock (in shares)				(3,200)
Charitable donation of Class A common stock (in shares)				300
Other comprehensive income (loss), net	$ (4,454)
Net loss	(123,799)	$ (105,657)	$ (18,142)
Ending balance (in shares) at Oct. 31, 2023		488,021	82,453	488,021	82,453	(3,239)
Ending balance at Oct. 31, 2023	1,961,213			$ 5	$ 1	$ (52,649)	3,958,795	3,158	(1,948,097)
Beginning balance (in shares) at Apr. 30, 2023				478,122	82,453
Beginning balance at Apr. 30, 2023	1,955,537			$ 5	$ 1		3,801,656	10,074	(1,856,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,824
Issuance of common stock upon exercise of stock options	2,717						2,717
Issuance of common stock upon settlement of restricted stock units (in shares)				5,026
Tax withholdings on settlement of restricted stock units (in shares)				(1,676)
Tax withholdings on settlement of restricted stock units	(27,420)						(27,420)
Issuance of common stock under employee stock purchase plan (in shares)				832
Issuance of common stock under employee stock purchase plan	9,313						9,313
Stock-based compensation	102,148						102,148
Other comprehensive income (loss), net	1,432							1,432
Net loss	(60,361)								(60,361)
Ending balance (in shares) at Jul. 31, 2023				484,128	82,453	0
Ending balance at Jul. 31, 2023	1,983,366			$ 5	$ 1	$ 0	3,888,414	11,506	(1,916,560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				837
Issuance of common stock upon exercise of stock options	1,516						1,516
Vesting of early exercised stock options	1						1
Issuance of common stock upon settlement of restricted stock units (in shares)				4,639
Tax withholdings on settlement of restricted stock units (in shares)				(1,583)
Tax withholdings on settlement of restricted stock units	(27,047)						(27,047)
Repurchase of Class A common stock (in shares)				(3,200)		(3,239)
Repurchase of Class A common stock	(52,649)					$ (52,649)
Stock-based compensation	95,911						95,911
Other comprehensive income (loss), net	(8,348)							(8,348)
Net loss	(31,537)	$ (26,951)	$ (4,586)						(31,537)
Ending balance (in shares) at Oct. 31, 2023		488,021	82,453	488,021	82,453	(3,239)
Ending balance at Oct. 31, 2023	$ 1,961,213			$ 5	$ 1	$ (52,649)	$ 3,958,795	$ 3,158	$ (1,948,097)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities
Net loss	$ (123,799)	$ (300,663)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	16,555	12,993
Amortization of deferred contract acquisition costs	52,828	37,967
Net amortization on marketable securities	(19,556)	501
Stock-based compensation expense	283,025	270,797
Charitable donation of Class A common stock	4,215	5,499
Amortization of operating lease right-of-use assets	9,663	8,555
Provision for deferred income taxes	(1,040)	1,171
Abandonment and impairment charges	0	2,881
Other non-cash credits, net	(4,864)	(1,714)
Changes in operating assets and liabilities:
Accounts receivable	(1,507)	(33,449)
Contract assets	(14,875)	(27,735)
Deferred contract acquisition costs	(71,727)	(69,657)
Prepaid expenses and other assets	17,247	(27,361)
Accounts payable	5,767	2,414
Accrued expenses and other liabilities	22,309	(13,785)
Accrued compensation and employee benefits	(40,590)	(26,096)
Operating lease liabilities, net	(10,296)	(488)
Deferred revenue	30,125	54,232
Net cash provided by (used in) operating activities	153,480	(103,938)
Cash flows from investing activities
Purchases of marketable securities	(1,006,606)	(204,311)
Maturities of marketable securities	576,480	93,298
Purchases of property and equipment	(3,558)	(21,614)
Payments related to business acquisition, net of cash acquired	0	(29,542)
Other investing, net	2,754	(507)
Net cash used in investing activities	(430,930)	(162,676)
Cash flows from financing activities
Repurchases of Class A common stock	(52,649)	0
Proceeds from exercise of stock options	5,421	7,605
Payments of tax withholdings on net settlement of equity awards	(75,495)	(53,300)
Net payments of tax withholdings on sell-to-cover equity award transactions	(645)	(10,132)
Proceeds from employee stock purchase plan contributions	14,253	13,525
Payment of deferred consideration related to business acquisition	(5,863)	0
Repurchase of unvested early exercised stock options	0	(1,493)
Net cash used in financing activities	(114,978)	(43,795)
Effect of exchange rate changes	(6,167)	(7,162)
Net decrease in cash, cash equivalents, and restricted cash	(398,595)	(317,571)
Cash, cash equivalents, and restricted cash - beginning of period	1,402,119	1,768,723
Cash, cash equivalents, and restricted cash - end of period	1,003,524	1,451,152
Supplemental disclosure of cash flow information
Cash paid for interest	515	720
Cash paid for income taxes	9,136	19,060
Supplemental disclosure of non-cash investing and financing activities
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options	1	1,355
Value of shares issued in payment of business acquisitions	0	2,965
Payable for marketable securities purchase	9,747	2,894
Loan notes issued in connection with business acquisitions	0	11,433
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	$ 6,833	$ 2,517

Organization and Description of

Organization and Description of Business	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies , in the notes to consolidated financial statements included in the 2023 Form 10-K. There have been no significant changes to such policies during the nine months ended October 31, 2023. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the nine months ended October 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended October 31, 2023 and 2022, we recognized transaction gains (losses) of $4.3 million and $(0.4) million, respectively. For the nine months ended October 31, 2023 and 2022, we recognized transaction gains (losses) of $2.9 million and $(2.6) million, respectively. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2023 and January 31, 2023, 93% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and nine months ended October 31, 2023 and 2022, no single customer accounted for 10% or more of our total revenue. As of October 31, 2023, one customer accounted for 12% of our accounts receivable. As of January 31, 2023, no single customer accounted for 10% or more of our accounts receivable. Stock-Based Compensation We recognize stock-based compensation expense in accordance with the provisions of Accounting Standards Codification ("ASC") 718, Compensation—Stock Compensation . ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards. The fair value of each stock option is determined using the Black-Scholes pricing model. The fair value of each restricted stock unit ("RSU") and restricted stock award ("RSA") is determined based on the fair value of our Class A common stock on the grant date. The fair value of each performance stock unit ("PSU") that is dependent on the satisfaction of a performance condition is also determined based on the fair value of our Class A common stock on the grant date.The fair value of shares under our employee stock purchase plan ("ESPP") is determined using the Black-Scholes pricing model. Stock-based compensation expense is included in cost of revenue and operating expenses within our consolidated statements of operations based on the expense classification of the individual earning the award. The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis. For PSUs dependent on the satisfaction of a performance condition, compensation expense is recognized only when management believes it is probable that the performance condition will be achieved. Although total compensation expense recognized for these awards will ultimately equal the grant date fair value per share multiplied by the number of shares earned by the holder, changes in management's expectations can cause fluctuations in timing of expense over the life of these awards. The fair value of ESPP shares is recognized over the relevant offering period on a straight-line basis. With all award types, we account for forfeitures as they occur. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended October 31, 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Americas (1) $ 174,226 53 % $ 147,312 56 % Europe, Middle East, and Africa 93,782 29 % 65,880 25 % Asia-Pacific (2) 57,913 18 % 49,552 19 % Total revenue $ 325,921 100 % $ 262,744 100 % (1) Revenue from the U.S. represented 48% and 52% of our total revenues for the three months ended October 31, 2023 and 2022, respectively. (2) Revenue from Japan represented 7% and 7% of our total revenues for the three months ended October 31, 2023 and 2022, respectively. Nine Months Ended October 31, 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Americas (1) $ 437,396 48 % $ 382,440 51 % Europe, Middle East, and Africa 271,722 30 % 205,004 27 % Asia-Pacific (2) 193,701 22 % 162,588 22 % Total revenue $ 902,819 100 % $ 750,032 100 % (1) Revenue from the U.S. represented 44% and 47% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively. (2) Revenue from Japan represented 10% and 10% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively. Deferred Revenue During the nine months ended October 31, 2023 and 2022, we recognized $331.1 million and $268.8 million of revenue that was included in the deferred revenue balance as of January 31, 2023 and 2022, respectively . Remaining Performance Obligations Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of October 31, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $994.6 million, which consists of $538.4 million of billed consideration and $456.2 million of unbilled consideration. We expect to recognize 60% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter. Deferred Contract Acquisition Costs Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $21.6 million and $16.1 million for the three months ended October 31, 2023 and 2022, respectively, and $52.8 million and $38.0 million for the nine months ended October 31, 2023 and 2022, respectively, and is recorded in sal es and marketing expense in the condensed consolidated statements of operations.

Marketable Securities

Marketable Securities	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The following is a summary of our marketable securities (in thousands): As of October 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Commercial paper $ 23,853 $ — $ — $ 23,853 Treasury bills and U.S. government securities 602,927 — (150) 602,777 Corporate bonds 5,625 — (14) 5,611 Municipal bonds 1,000 — (2) 998 Agency bonds 181,054 — (196) 180,858 Total marketable securities $ 814,459 $ — $ (362) $ 814,097 As of January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Commercial paper $ 62,470 $ — $ — $ 62,470 Treasury bills and U.S. government securities (1) 234,848 — (308) 234,540 Corporate bonds 46,684 — (198) 46,486 Municipal bonds 6,374 — (66) 6,308 Agency bonds 7,959 — (47) 7,912 Total marketable securities $ 358,335 $ — $ (619) $ 357,716 (1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less. As of October 31, 2023 and January 31, 2023, none and $2.9 million, respectively, of our marketable securities had remaining contractual maturities of one year or more. As of October 31, 2023 and January 31, 2023, $3.3 million and $3.5 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of October 31, 2023 and January 31, 2023. Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

Fair Value Measurement

Fair Value Measurement	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2023 and January 31, 2023 (in thousands): As of October 31, 2023 Level 1 Level 2 Total Money market $ 468,683 $ — $ 468,683 Total cash equivalents 468,683 — 468,683 Commercial paper — 23,853 23,853 Treasury bills and U.S. government securities 602,777 — 602,777 Corporate bonds — 5,611 5,611 Municipal bonds — 998 998 Agency bonds 180,858 — 180,858 Total marketable securities 783,635 30,462 814,097 Total $ 1,252,318 $ 30,462 $ 1,282,780 As of January 31, 2023 Level 1 Level 2 Total Money market $ 319,801 $ — $ 319,801 Treasury bills 9,968 — 9,968 Total cash equivalents 329,769 — 329,769 Commercial paper — 62,470 62,470 Treasury bills and U.S. government securities 234,540 — 234,540 Corporate bonds — 46,486 46,486 Municipal bonds — 6,308 6,308 Agency bonds 7,912 — 7,912 Total marketable securities 242,452 115,264 357,716 Total $ 572,221 $ 115,264 $ 687,485 Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper, corporate bonds, and municipal bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of October 31, 2023 or January 31, 2023.

Business Acquisition

Business Acquisition	9 Months Ended
	Oct. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Acquisition	Business Acquisition Re:infer On July 29, 2022, we acquired all of the outstanding capital stock of Re:infer LTD. (“Re:infer”), a natural language processing company focused on unstructured documents and communications. Re:infer uses machine learning technology to mine context from communication messages and transform them into actionable data. With this acquisition, we gained technology and an experienced team which we believe will accelerate our technology roadmap, expand the breadth of our current AI-powered automation capabilities, and unlock new automation opportunities for our customers. The Re:infer acquisition was accounted for as a business combination. The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands): Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note paid on July 29, 2023 (first anniversary of closing) 5,863 Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of October 31, 2023) 5,570 Working capital adjustment 66 Total $ 44,581 At closing, we also issued an additional 0.4 million shares of Class A common stock to be released to sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to certain employment-related clawback provisions. The aggregate fair value of these shares totaled $7.6 million and is expensed as compensation for post-acquisition services over the three years following the acquisition date. The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands): July 29, 2022 Net tangible assets $ 300 Intangible assets 13,100 Goodwill 34,351 Total assets acquired 47,751 Deferred tax liabilities assumed (3,170) Total $ 44,581 The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Estimated Useful Life Developed technology $ 10,000 5.0 Customer relationships 3,100 3.0 Total $ 13,100 The acquisition of Re:infer generated goodwill of $34.4 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets, Net Acquired intangible assets, net consisted of the following as of October 31, 2023 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (in years) Developed technology $ 28,241 $ (15,206) $ 13,035 3.0 Customer relationships 8,135 (5,577) 2,558 1.4 Trade names and trademarks 271 (257) 14 0.4 Other intangibles 1,231 (378) 853 7.2 Total $ 37,878 $ (21,418) $ 16,460 Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (in years) Developed technology $ 28,517 $ (11,095) $ 17,422 3.5 Customer relationships 8,174 (3,601) 4,573 2.0 Trade names and trademarks 272 (233) 39 1.2 Other intangibles 1,231 (255) 976 7.7 Total $ 38,194 $ (15,184) $ 23,010 We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended October 31, 2023 and 2022 was $2.1 million and $2.1 million, respectively, and for the nine months ended October 31, 2023 and 2022 was $6.4 million and $4.8 million, respectively. Expected future amortization expense related to intangible assets was as follows as of October 31, 2023 (in thousands): Amount Remainder of year ending January 31, 2024 $ 2,123 Year ending January 31, 2025 6,538 2026 4,004 2027 2,369 2028 1,123 Thereafter 303 Total $ 16,460 Goodwill Changes in the carrying amount of goodwill during the nine months ended October 31, 2023 were as follows (in thousands): Carrying Amount Balance as of January 31, 2023 $ 88,010 Effect of foreign currency translation (717) Balance as of October 31, 2023 $ 87,293

Operating Leases

Operating Leases	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Operating Leases	Operating Leases Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. F or purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees. Lease costs are presented below (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Operating lease cost $ 3,364 $ 3,060 $ 9,663 $ 8,555 Short-term lease cost 1,225 1,509 3,845 4,552 Variable lease cost 493 362 1,639 885 Sublease income (1) (426) (532) (1,491) (1,597) Total $ 4,656 $ 4,399 $ 13,656 $ 12,395 (1) Included in other income (expense), net in the condensed consolidated statements of operations. The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of October 31, 2023 January 31, 2023 Weighted-average remaining lease term (years) 11.2 12.1 Weighted-average discount rate 7.0 % 7.0 % Future undiscounted lease payments for our operating lease liabilities as of October 31, 2023 were as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 1,849 Year ending January 31, 2025 12,284 2026 10,173 2027 9,432 2028 8,748 Thereafter 49,931 Total operating lease payments 92,417 Less: imputed interest (27,825) Total operating lease liabilities $ 64,592 As of October 31, 2023, we had non-cancellable commitments in the amount of $0.5 million related to operating leases of real estate facilities that have not yet commenced. Current operating lease liabilities of $6.9 million and $7.0 million were included in accrued expenses and other current liabilities Supplemental cash flow information related to leases for the three and nine months ended October 31, 2023 and 2022 was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 3,486 $ 1,721 $ 9,646 $ 5,278 Operating lease ROU assets obtained in exchange for new operating lease liabilities 4,139 5,769 8,820 8,659

Condensed Consolidated Balanc_3

Condensed Consolidated Balance Sheet Components	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Balance Sheet Components	Condensed Consolidated Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of October 31, 2023 January 31, 2023 Prepaid expenses and service credits $ 65,755 $ 67,794 Other current assets 25,469 26,356 Prepaid expenses and other current assets $ 91,224 $ 94,150 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of October 31, 2023 January 31, 2023 Computers and equipment $ 28,164 $ 28,450 Leasehold improvements 21,860 19,622 Furniture and fixtures 6,751 6,485 Construction in progress 533 2,419 Property and equipment, gross 57,308 56,976 Less: accumulated depreciation (34,804) (27,931) Property and equipment, net $ 22,504 $ 29,045 Depreciation expense for the three months ended October 31, 2023 and 2022 was $2.7 million and $2.2 million, respectively. Depreciation expense for the nine months ended October 31, 2023 and 2022 was $8.5 million and $6.0 million, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of October 31, 2023 January 31, 2023 Accrued expenses $ 25,079 $ 19,411 Withholding tax from employee equity transactions 6,950 3,772 Employee stock purchase plan withholdings 8,217 3,365 Payroll taxes and other benefits payable 6,722 7,644 Income tax payable 12,774 8,750 Value-added taxes payable 4,342 6,381 Operating lease liabilities, current 6,905 6,997 Deferred consideration for business acquisition, current 5,570 5,863 Payable for marketable securities purchase (1) 9,747 3,588 Other 21,708 10,874 Accrued expenses and other current liabilities $ 108,014 $ 76,645 (1) Prior period amount has been broken out to conform with current period presentation

Credit Facility

Credit Facility	9 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Credit Facility	Credit Facility On October 30, 2020 we entered into a $200.0 million senior secured revolving credit facility with a maturity date of October 30, 2023 (as subsequently amended, the “Credit Facility”) with HSBC Ventures USA Inc., Silicon Valley Bank, a division of First Citizens Bank & Trust Company (successor by purchase to the FDIC as receiver for Silicon Valley Bridge Bank, N.A. (as successor to Silicon Valley Bank)), Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD (together, the "Lenders"). The Credit Facility contained certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit We had a total of $3.2 million and $4.3 million in letters of credit outstanding in favor of certain landlords for office space and for credit line facilities as of October 31, 2023 and January 31, 2023, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2025. Indemnification In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of October 31, 2023 and January 31, 2023, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote. Restructuring On June 24, 2022, our board of directors approved restructuring actions to manage our operating expenses by reducing our global workforce by approximately 5%. The workforce reduction aimed to simplify our go-to-market approach and improve sales productivity. In connection with these workforce reductions, we also ceased use of our office in Brooklyn, NY. On November 10, 2022, our board of directors approved further restructuring actions to reduce our global workforce across functions by an additional 6%. For the nine months ended October 31, 2023, we incurred $2.6 million of expense associated with employee termination benefits in connection our restructuring actions, which were completed during the second quarter of fiscal year 2024. The following table shows the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of October 31, 2023 (in thousands): Employee Termination Benefits Accrued restructuring costs as of January 31, 2023 $ 3,889 Restructuring costs incurred during the nine months ended October 31, 2023 2,631 Amount paid during the nine months ended October 31, 2023 (6,072) Accrued restructuring costs as of October 31, 2023 $ 448 Defined Contribution Plans We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans was $3.3 million and $2.7 million for the three months ended October 31, 2023 and 2022, respectively, and $12.4 million and $11.4 million for the nine months ended October 31, 2023 and 2022, respectively. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters, which arise in the ordinary course of business. In accordance with ASC 450, Contingencies , we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. UiPath and certain of its officers are currently parties to the following litigation matters: On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, Co-CEO Daniel Dines, and CFO Ashim Gupta, captioned Samhita Gera v. UiPath, Inc., et. al. (Case No. 1:23-cv-07908) (the "Securities Action"). The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act, and alleges that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. The complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and March 30, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. The proceeding is at a very early stage. On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al. (Case No. 1:23-cv-08810). The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the Securities Action and by causing the Company to repurchase shares at inflated prices.The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees, and certain changes to UiPath’s corporate governance and internal controls. The proceeding is at a very early stage. We have not recorded any accrual related to the aforementioned litigation matters as of October 31, 2023. Warranty We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made. Non-Cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and credits toward purchase of products and services from strategic alliance partners. As of October 31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 11,164 Year ending January 31, 2025 91,225 2026 64,667 2027 21,679 2028 8,245 Thereafter — Total $ 196,980

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Stock Repurchase Program On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future. During the three and nine months ended October 31, 2023, we repurchased 3.2 million shares of our Class A common stock at an average price of $16.26 per share (inclusive of brokerage commission). Subsequent to October 31, 2023, between November 1, 2023 and November 28, 2023, we repurchased an additional 1.7 million shares of our Class A common stock at an average price of $17.38 per share. Charitable Donations of Class A Common Stock We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. During the nine months ended October 31, 2023, we contributed 0.3 million shares of our Class A common stock to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair value of the shares on the contribution date of $4.2 million was recorded within general and administrative expense in the condensed consolidated statements of operations. Accumulated Other Comprehensive Income (Loss) For the nine months ended October 31, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive (loss) income, net of tax (4,713) 259 (4,454) Balance as of October 31, 2023 $ 3,518 $ (360) $ 3,158 Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive loss, net of tax (3,321) (625) (3,946) Balance as of October 31, 2022 $ 7,913 $ (960) $ 6,953

Equity Incentive Plans and Stoc

Equity Incentive Plans and Stock-Based Compensation	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans and Stock-Based Compensation	Equity Incentive Plans and Stock-Based Compensation 2021 Stock Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, RSAs, RSUs, PSUs, and other forms of awards. As of October 31, 2023, we have reserved 173.7 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase. 2021 Employee Stock Purchase Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of October 31, 2023, the ESPP authorizes the issuance of 21.5 million shares of our Class A common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of each offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date. Stock Options Stock option activity during the nine months ended October 31, 2023 was as follows: Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value Outstanding as of January 31, 2023 13,898 $ 3.32 7.7 $ 169,324 Granted 2,763 $ 0.10 Exercised (3,559) $ 1.52 Forfeited (361) $ 0.51 Outstanding as of October 31, 2023 12,741 $ 3.20 7.6 $ 158,811 Vested and exercisable as of October 31, 2023 6,252 $ 3.68 6.4 $ 74,680 The weighted-average grant date fair value of stock options granted during the nine months ended October 31, 2023 was $16.56 per share. The intrinsic value of stock options exercised during the nine months ended October 31, 2023 was $55.4 million. Unrecognized compensation expense associated with unvested stock options granted and outstanding as of October 31, 2023, was approximately $113.0 million, which is to be recognized over a weighted-average remaining period of 2.3 years. Restricted Stock Units RSU activity during the nine months ended October 31, 2023 was as follows: RSUs Weighted-Average Grant Date Fair Value Per Share Unvested as of January 31, 2023 36,785 $ 22.48 Granted 17,615 $ 16.54 Vested (13,773) $ 20.47 Forfeited (6,569) $ 23.46 Unvested as of October 31, 2023 34,058 $ 20.03 The vesting date fair value of RSUs that vested during the nine months ended October 31, 2023 was $236.2 million. As of October 31, 2023, total unrecognized compensation expense related to unvested RSUs was approximately $612.6 million, which is to be recognized over a weighted-average remaining period of 2.4 years. Restricted Stock Awards In September 2020, we issued approximately 0.1 million RSAs to a member of our board of directors at a grant date fair value of $33.22 per share, totaling $4.0 million. Such RSAs vest monthly over four years from the grant date. The unvested shares are subject to a repurchase right held by us. As of October 31, 2023, total unrecognized compensation expense related to unvested RSAs was $0.9 million and will be recognized over the remaining vesting period of 0.9 years. Performance Stock Units In July 2023, we granted approximately 0.1 million PSUs at a grant date fair value of $18.08 per share. The PSUs are subject to performance conditions related to the achievement of certain individual and Company targets for fiscal year 2024, and the number of shares earned will ultimately be 0%, 100%, or 200% of the base number of PSUs awarded. To the extent that they are earned, these PSUs will vest on April 1, 2024. Employee Stock Purchase Plan Awards During the nine months ended October 31, 2023, 0.8 million shares were purchased under the ESPP at $11.19 per share. As of October 31, 2023, total unrecognized compensation expense related to the ESPP was approximately $0.7 million, which is to be recognized over a weighted-average remaining period of 0.1 years. Stock-Based Compensation Associated with Business Acquisition At the closing of the acquisition of Re:infer on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of October 31, 2023, total unrecognized compensation expense related to these shares was $4.5 million, which is to be recognized over a weighted-average remaining period of 1.8 years. Stock-Based Compensation Expense Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cost of subscription services revenue $ 3,791 $ 2,844 $ 10,778 $ 8,901 Cost of professional services and other revenue 2,764 2,557 8,546 8,959 Sales and marketing 37,760 30,763 109,890 117,410 Research and development 30,604 23,435 88,448 73,559 General and administrative 20,961 21,492 65,363 61,968 Total $ 95,880 $ 81,091 $ 283,025 $ 270,797

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. We had a provision for income taxes of $3.9 million, reflecting an effective tax rate of (14.2%), and $1.2 million, reflecting an effective tax rate of (2.1%), for the three months ended October 31, 2023 and 2022, respectively. For the three months ended October 31, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. We had a provision for income taxes of $11.4 million, reflecting an effective tax rate of (10.1%), and $10.1 million, reflecting an effective tax rate of (3.5%), for the nine months ended October 31, 2023 and 2022, respectively. For the nine months ended October 31, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing DTAs for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the nine months ended October 31, 2023, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. may not be realized. Accordingly, we recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of October 31, 2023, there is no valuation allowance recorded against DTAs associated with Japan as we believe it is more likely than not that we will realize such assets during the prescribed statutory period. As of October 31, 2023, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $1.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. The tax positions of UiPath, Inc. and its subsidiaries are subject to income tax audits in multiple tax jurisdictions globally, with currently open audits in Romania and India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us. During the three months ended October 31, 2023, Romania adopted a minimum alternative corporate income tax that is applicable to all companies, including those reporting a net loss, for tax years commencing after January 1, 2024. Given our presence in Romania, we expect this change to increase our effective tax rate and immaterially increase our provision for income taxes for fiscal year 2025.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Three Months Ended October 31, 2023 2022 Class A Class B Class A Class B Numerator: Net loss $ (26,951) $ (4,586) $ (49,073) $ (8,651) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 484,583 82,453 467,711 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.06) $ (0.10) $ (0.10) Nine Months Ended October 31, 2023 2022 Class A Class B Class A Class B Numerator: Net loss $ (105,657) $ (18,142) $ (255,266) $ (45,397) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 480,198 82,453 463,634 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.22) $ (0.22) $ (0.55) $ (0.55) Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Three Months Ended October 31, 2023 2022 Class A Class B Class A Class B Unvested RSUs 36,911 — 31,022 — Outstanding stock options 13,207 — 13,812 — Shares subject to repurchase from RSAs and early exercised stock options 52 — 104 — Shares issuable under ESPP 714 — 936 — Returnable shares issued in connection with business acquisition 274 — 427 — Total 51,158 — 46,301 — Nine Months Ended October 31, 2023 2022 Class A Class B Class A Class B Unvested RSUs 38,137 — 29,307 — Outstanding stock options 13,764 — 13,913 — Shares subject to repurchase from RSAs and early exercised stock options 56 — 355 — Shares issuable under ESPP 762 — 851 — Returnable shares issued in connection with business acquisition 374 — 149 — Total 53,093 — 44,575 —

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Beginning in the third quarter of fiscal year 2022, we have at times made use of an aircraft which is owned by Daniel Dines, our Co-Chief Executive Officer, through a special purpose limited liability company and which is operated by a third-party aircraft management company. Mr. Dines, through the special purpose limited liability company, obtained financing for the aircraft and bears all associated operating, personnel, and maintenance costs. We did not incur any expense related to use of the aircraft for the three and nine months ended October 31, 2023. For the three and nine months ended October 31, 2022, we incurred no expense and $1.9 million of expense, respectively in connection with our business use of the aircraft.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (31,537)	$ (60,361)	$ (31,901)	$ (57,724)	$ (120,378)	$ (122,561)	$ (123,799)	$ (300,663)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Richard P.Wong [Member]
Trading Arrangements, by Individual
Name	Richard P. Wong
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 9, 2023
Arrangement Duration	91 days
Aggregate Available	500,000
Ashim Gupta [Member]
Trading Arrangements, by Individual
Name	Ashim Gupta
Title	CFO
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 22, 2023
Arrangement Duration	178 days
Aggregate Available	315,000
Ashim Gupta Family Trust [Member]
Trading Arrangements, by Individual
Arrangement Duration	178 days
Aggregate Available	96,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the nine months ended October 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign Currency
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2023 and January 31, 2023, 93% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.
Stock-Based Compensation	Stock-Based Compensation We recognize stock-based compensation expense in accordance with the provisions of Accounting Standards Codification ("ASC") 718, Compensation—Stock Compensation . ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards. The fair value of each stock option is determined using the Black-Scholes pricing model. The fair value of each restricted stock unit ("RSU") and restricted stock award ("RSA") is determined based on the fair value of our Class A common stock on the grant date. The fair value of each performance stock unit ("PSU") that is dependent on the satisfaction of a performance condition is also determined based on the fair value of our Class A common stock on the grant date.The fair value of shares under our employee stock purchase plan ("ESPP") is determined using the Black-Scholes pricing model. Stock-based compensation expense is included in cost of revenue and operating expenses within our consolidated statements of operations based on the expense classification of the individual earning the award. The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis. For PSUs dependent on the satisfaction of a performance condition, compensation expense is recognized only when management believes it is probable that the performance condition will be achieved. Although total compensation expense recognized for these awards will ultimately equal the grant date fair value per share multiplied by the number of shares earned by the holder, changes in management's expectations can cause fluctuations in timing of expense over the life of these awards. The fair value of ESPP shares is recognized over the relevant offering period on a straight-line basis. With all award types, we account for forfeitures as they occur.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Geographical Region	The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended October 31, 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Americas (1) $ 174,226 53 % $ 147,312 56 % Europe, Middle East, and Africa 93,782 29 % 65,880 25 % Asia-Pacific (2) 57,913 18 % 49,552 19 % Total revenue $ 325,921 100 % $ 262,744 100 % (1) Revenue from the U.S. represented 48% and 52% of our total revenues for the three months ended October 31, 2023 and 2022, respectively. (2) Revenue from Japan represented 7% and 7% of our total revenues for the three months ended October 31, 2023 and 2022, respectively. Nine Months Ended October 31, 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Americas (1) $ 437,396 48 % $ 382,440 51 % Europe, Middle East, and Africa 271,722 30 % 205,004 27 % Asia-Pacific (2) 193,701 22 % 162,588 22 % Total revenue $ 902,819 100 % $ 750,032 100 % (1) Revenue from the U.S. represented 44% and 47% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively. (2) Revenue from Japan represented 10% and 10% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

Marketable Securities (Tables)

Marketable Securities (Tables)	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	The following is a summary of our marketable securities (in thousands): As of October 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Commercial paper $ 23,853 $ — $ — $ 23,853 Treasury bills and U.S. government securities 602,927 — (150) 602,777 Corporate bonds 5,625 — (14) 5,611 Municipal bonds 1,000 — (2) 998 Agency bonds 181,054 — (196) 180,858 Total marketable securities $ 814,459 $ — $ (362) $ 814,097 As of January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Commercial paper $ 62,470 $ — $ — $ 62,470 Treasury bills and U.S. government securities (1) 234,848 — (308) 234,540 Corporate bonds 46,684 — (198) 46,486 Municipal bonds 6,374 — (66) 6,308 Agency bonds 7,959 — (47) 7,912 Total marketable securities $ 358,335 $ — $ (619) $ 357,716 (1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2023 and January 31, 2023 (in thousands): As of October 31, 2023 Level 1 Level 2 Total Money market $ 468,683 $ — $ 468,683 Total cash equivalents 468,683 — 468,683 Commercial paper — 23,853 23,853 Treasury bills and U.S. government securities 602,777 — 602,777 Corporate bonds — 5,611 5,611 Municipal bonds — 998 998 Agency bonds 180,858 — 180,858 Total marketable securities 783,635 30,462 814,097 Total $ 1,252,318 $ 30,462 $ 1,282,780 As of January 31, 2023 Level 1 Level 2 Total Money market $ 319,801 $ — $ 319,801 Treasury bills 9,968 — 9,968 Total cash equivalents 329,769 — 329,769 Commercial paper — 62,470 62,470 Treasury bills and U.S. government securities 234,540 — 234,540 Corporate bonds — 46,486 46,486 Municipal bonds — 6,308 6,308 Agency bonds 7,912 — 7,912 Total marketable securities 242,452 115,264 357,716 Total $ 572,221 $ 115,264 $ 687,485

Business Acquisition (Tables)

Business Acquisition (Tables)	9 Months Ended
	Oct. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Total Purchase Consideration	The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands): Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note paid on July 29, 2023 (first anniversary of closing) 5,863 Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of October 31, 2023) 5,570 Working capital adjustment 66 Total $ 44,581
Schedule of Fair Values of Assets Acquired and Liabilities Assumed	The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands): July 29, 2022 Net tangible assets $ 300 Intangible assets 13,100 Goodwill 34,351 Total assets acquired 47,751 Deferred tax liabilities assumed (3,170) Total $ 44,581
Schedule of Identifiable Intangible Assets Acquired and their Estimated Useful Lives	The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Estimated Useful Life Developed technology $ 10,000 5.0 Customer relationships 3,100 3.0 Total $ 13,100

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Acquired intangible assets, net consisted of the following as of October 31, 2023 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (in years) Developed technology $ 28,241 $ (15,206) $ 13,035 3.0 Customer relationships 8,135 (5,577) 2,558 1.4 Trade names and trademarks 271 (257) 14 0.4 Other intangibles 1,231 (378) 853 7.2 Total $ 37,878 $ (21,418) $ 16,460 Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands): Intangible Assets, Gross Accumulated Amortization Intangible Assets, Net Weighted-Average Remaining Useful Life (in years) Developed technology $ 28,517 $ (11,095) $ 17,422 3.5 Customer relationships 8,174 (3,601) 4,573 2.0 Trade names and trademarks 272 (233) 39 1.2 Other intangibles 1,231 (255) 976 7.7 Total $ 38,194 $ (15,184) $ 23,010
Schedule of Expected Future Amortization Expenses Related to Intangible Assets	Expected future amortization expense related to intangible assets was as follows as of October 31, 2023 (in thousands): Amount Remainder of year ending January 31, 2024 $ 2,123 Year ending January 31, 2025 6,538 2026 4,004 2027 2,369 2028 1,123 Thereafter 303 Total $ 16,460
Schedule of Changes in Carrying Amounts of Goodwill	Changes in the carrying amount of goodwill during the nine months ended October 31, 2023 were as follows (in thousands): Carrying Amount Balance as of January 31, 2023 $ 88,010 Effect of foreign currency translation (717) Balance as of October 31, 2023 $ 87,293

Operating Leases (Tables)

Operating Leases (Tables)	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Schedule of Lease Costs and Supplemental Cash Flow Information	Lease costs are presented below (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Operating lease cost $ 3,364 $ 3,060 $ 9,663 $ 8,555 Short-term lease cost 1,225 1,509 3,845 4,552 Variable lease cost 493 362 1,639 885 Sublease income (1) (426) (532) (1,491) (1,597) Total $ 4,656 $ 4,399 $ 13,656 $ 12,395 (1) Included in other income (expense), net in the condensed consolidated statements of operations. Supplemental cash flow information related to leases for the three and nine months ended October 31, 2023 and 2022 was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 3,486 $ 1,721 $ 9,646 $ 5,278 Operating lease ROU assets obtained in exchange for new operating lease liabilities 4,139 5,769 8,820 8,659
Schedule of Weighted-average Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of October 31, 2023 January 31, 2023 Weighted-average remaining lease term (years) 11.2 12.1 Weighted-average discount rate 7.0 % 7.0 %
Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities	Future undiscounted lease payments for our operating lease liabilities as of October 31, 2023 were as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 1,849 Year ending January 31, 2025 12,284 2026 10,173 2027 9,432 2028 8,748 Thereafter 49,931 Total operating lease payments 92,417 Less: imputed interest (27,825) Total operating lease liabilities $ 64,592

Condensed Consolidated Balanc_4

Condensed Consolidated Balance Sheet Components (Tables)	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of October 31, 2023 January 31, 2023 Prepaid expenses and service credits $ 65,755 $ 67,794 Other current assets 25,469 26,356 Prepaid expenses and other current assets $ 91,224 $ 94,150
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of October 31, 2023 January 31, 2023 Computers and equipment $ 28,164 $ 28,450 Leasehold improvements 21,860 19,622 Furniture and fixtures 6,751 6,485 Construction in progress 533 2,419 Property and equipment, gross 57,308 56,976 Less: accumulated depreciation (34,804) (27,931) Property and equipment, net $ 22,504 $ 29,045
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of October 31, 2023 January 31, 2023 Accrued expenses $ 25,079 $ 19,411 Withholding tax from employee equity transactions 6,950 3,772 Employee stock purchase plan withholdings 8,217 3,365 Payroll taxes and other benefits payable 6,722 7,644 Income tax payable 12,774 8,750 Value-added taxes payable 4,342 6,381 Operating lease liabilities, current 6,905 6,997 Deferred consideration for business acquisition, current 5,570 5,863 Payable for marketable securities purchase (1) 9,747 3,588 Other 21,708 10,874 Accrued expenses and other current liabilities $ 108,014 $ 76,645 (1) Prior period amount has been broken out to conform with current period presentation

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Accrued Restructuring Costs	The following table shows the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of October 31, 2023 (in thousands): Employee Termination Benefits Accrued restructuring costs as of January 31, 2023 $ 3,889 Restructuring costs incurred during the nine months ended October 31, 2023 2,631 Amount paid during the nine months ended October 31, 2023 (6,072) Accrued restructuring costs as of October 31, 2023 $ 448
Schedule of Non-Cancelable Purchase Obligations	As of October 31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 11,164 Year ending January 31, 2025 91,225 2026 64,667 2027 21,679 2028 8,245 Thereafter — Total $ 196,980

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Schedule of Changes in Components of Accumulated Other Comprehensive Income (Loss)	For the nine months ended October 31, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive (loss) income, net of tax (4,713) 259 (4,454) Balance as of October 31, 2023 $ 3,518 $ (360) $ 3,158 Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive loss, net of tax (3,321) (625) (3,946) Balance as of October 31, 2022 $ 7,913 $ (960) $ 6,953

Equity Incentive Plans and St_2

Equity Incentive Plans and Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock option activity during the nine months ended October 31, 2023 was as follows: Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value Outstanding as of January 31, 2023 13,898 $ 3.32 7.7 $ 169,324 Granted 2,763 $ 0.10 Exercised (3,559) $ 1.52 Forfeited (361) $ 0.51 Outstanding as of October 31, 2023 12,741 $ 3.20 7.6 $ 158,811 Vested and exercisable as of October 31, 2023 6,252 $ 3.68 6.4 $ 74,680
Schedule of RSU Activity	RSU activity during the nine months ended October 31, 2023 was as follows: RSUs Weighted-Average Grant Date Fair Value Per Share Unvested as of January 31, 2023 36,785 $ 22.48 Granted 17,615 $ 16.54 Vested (13,773) $ 20.47 Forfeited (6,569) $ 23.46 Unvested as of October 31, 2023 34,058 $ 20.03
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cost of subscription services revenue $ 3,791 $ 2,844 $ 10,778 $ 8,901 Cost of professional services and other revenue 2,764 2,557 8,546 8,959 Sales and marketing 37,760 30,763 109,890 117,410 Research and development 30,604 23,435 88,448 73,559 General and administrative 20,961 21,492 65,363 61,968 Total $ 95,880 $ 81,091 $ 283,025 $ 270,797

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Three Months Ended October 31, 2023 2022 Class A Class B Class A Class B Numerator: Net loss $ (26,951) $ (4,586) $ (49,073) $ (8,651) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 484,583 82,453 467,711 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.06) $ (0.10) $ (0.10) Nine Months Ended October 31, 2023 2022 Class A Class B Class A Class B Numerator: Net loss $ (105,657) $ (18,142) $ (255,266) $ (45,397) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 480,198 82,453 463,634 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.22) $ (0.22) $ (0.55) $ (0.55)
Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share	Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Three Months Ended October 31, 2023 2022 Class A Class B Class A Class B Unvested RSUs 36,911 — 31,022 — Outstanding stock options 13,207 — 13,812 — Shares subject to repurchase from RSAs and early exercised stock options 52 — 104 — Shares issuable under ESPP 714 — 936 — Returnable shares issued in connection with business acquisition 274 — 427 — Total 51,158 — 46,301 — Nine Months Ended October 31, 2023 2022 Class A Class B Class A Class B Unvested RSUs 38,137 — 29,307 — Outstanding stock options 13,764 — 13,913 — Shares subject to repurchase from RSAs and early exercised stock options 56 — 355 — Shares issuable under ESPP 762 — 851 — Returnable shares issued in connection with business acquisition 374 — 149 — Total 53,093 — 44,575 —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gain (losses)	$ 4.3	$ (0.4)	$ 2.9	$ (2.6)
Customer Concentration Risk | Accounts Receivable | Customer One
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			12%
US, European Union (“EU”) Countries, and Japan | Geographic Concentration Risk | Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			93%		98%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue [Line Items]
Amount	$ 325,921	$ 262,744	$ 902,819	$ 750,032
Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Amount	$ 174,226	$ 147,312	$ 437,396	$ 382,440
Americas | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	53%	56%	48%	51%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Amount	$ 93,782	$ 65,880	$ 271,722	$ 205,004
Europe, Middle East, and Africa | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	29%	25%	30%	27%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Amount	$ 57,913	$ 49,552	$ 193,701	$ 162,588
Asia-Pacific | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	18%	19%	22%	22%
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	48%	52%	44%	47%
Japan | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	7%	7%	10%	10%

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized			$ 331,100	$ 268,800
Deferred contract acquisition costs	$ 21,600	$ 16,100	$ 52,828	$ 37,967

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Oct. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 994.6
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	538.4
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 456.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	60%
Remaining performance obligations, period	12 months

Marketable Securities - Summary

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 814,459	$ 358,335
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(362)	(619)
Estimated Fair Value	814,097	357,716
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	23,853	62,470
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	23,853	62,470
Treasury bills and U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	602,927	234,848
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(150)	(308)
Estimated Fair Value	602,777	234,540
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	5,625	46,684
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(14)	(198)
Estimated Fair Value	5,611	46,486
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,000	6,374
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(2)	(66)
Estimated Fair Value	998	6,308
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	181,054	7,959
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(196)	(47)
Estimated Fair Value	$ 180,858	7,912
Cash and cash equivalents | Treasury bills
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		10,000
Estimated Fair Value		$ 10,000

Marketable Securities - Additio

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 0	$ 2,942
Prepaid Expenses and Other Current Assets
Debt Securities, Available-for-sale [Line Items]
Interest receivable	$ 3,300	$ 3,500

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Financial assets:
Total marketable securities	$ 814,097	$ 357,716
Commercial paper
Financial assets:
Total marketable securities	23,853	62,470
Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	602,777	234,540
Corporate bonds
Financial assets:
Total marketable securities	5,611	46,486
Municipal bonds
Financial assets:
Total marketable securities	998	6,308
Agency bonds
Financial assets:
Total marketable securities	180,858	7,912
Recurring
Financial assets:
Total cash equivalents	468,683	329,769
Total marketable securities	814,097	357,716
Total	1,282,780	687,485
Recurring | Money market
Financial assets:
Total cash equivalents	468,683	319,801
Recurring | Treasury bills
Financial assets:
Total cash equivalents		9,968
Recurring | Commercial paper
Financial assets:
Total marketable securities	23,853	62,470
Recurring | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	602,777	234,540
Recurring | Corporate bonds
Financial assets:
Total marketable securities	5,611	46,486
Recurring | Municipal bonds
Financial assets:
Total marketable securities	998	6,308
Recurring | Agency bonds
Financial assets:
Total marketable securities	180,858	7,912
Recurring | Level 1
Financial assets:
Total cash equivalents	468,683	329,769
Total marketable securities	783,635	242,452
Total	1,252,318	572,221
Recurring | Level 1 | Money market
Financial assets:
Total cash equivalents	468,683	319,801
Recurring | Level 1 | Treasury bills
Financial assets:
Total cash equivalents		9,968
Recurring | Level 1 | Commercial paper
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	602,777	234,540
Recurring | Level 1 | Corporate bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Municipal bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Agency bonds
Financial assets:
Total marketable securities	180,858	7,912
Recurring | Level 2
Financial assets:
Total cash equivalents	0	0
Total marketable securities	30,462	115,264
Total	30,462	115,264
Recurring | Level 2 | Money market
Financial assets:
Total cash equivalents	0	0
Recurring | Level 2 | Treasury bills
Financial assets:
Total cash equivalents		0
Recurring | Level 2 | Commercial paper
Financial assets:
Total marketable securities	23,853	62,470
Recurring | Level 2 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	0	0
Recurring | Level 2 | Corporate bonds
Financial assets:
Total marketable securities	5,611	46,486
Recurring | Level 2 | Municipal bonds
Financial assets:
Total marketable securities	998	6,308
Recurring | Level 2 | Agency bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 3
Financial assets:
Total	$ 0	$ 0

Business Acquisition - Summary

Business Acquisition - Summary of Total Purchase Consideration (Details) - USD ($) $ in Thousands, shares in Millions		9 Months Ended
	Jul. 29, 2022	Oct. 31, 2023	Oct. 31, 2022
Business Acquisition [Line Items]
Loan notes issued in connection with business acquisitions		$ 0	$ 11,433
Re:infer
Business Acquisition [Line Items]
Cash paid at closing	$ 30,117
Fair value of Class A common stock issued at closing (0.2 million shares)	2,965
Working capital adjustment	66
Total purchase consideration	$ 44,581
Stock issued at closing (in shares)	0.2
Re:infer | First Anniversary of Closing
Business Acquisition [Line Items]
Loan notes issued in connection with business acquisitions	$ 5,863
Re:infer | Second Anniversary of Closing
Business Acquisition [Line Items]
Loan notes issued in connection with business acquisitions	$ 5,570

Business Acquisition - Addition

Business Acquisition - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions		9 Months Ended
	Jul. 29, 2022	Oct. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Purchase price allocation to goodwill		$ 87,293	$ 88,010
Re:infer
Business Acquisition [Line Items]
Total purchase consideration	$ 44,581
Stock issued at closing subject to clawback provisions (in shares)	0.4
Purchase price allocation to goodwill	$ 34,351
Goodwill deductible for tax purposes	0
Re:infer | Common Stock
Business Acquisition [Line Items]
Unrecognized compensation expense	$ 7,600	$ 4,500
Weighted-average remaining period	3 years	1 year 9 months 18 days

Business Acquisition - Summar_2

Business Acquisition - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023	Jul. 29, 2022
Business Acquisition [Line Items]
Goodwill	$ 87,293	$ 88,010
Re:infer
Business Acquisition [Line Items]
Net tangible assets			$ 300
Intangible assets			13,100
Goodwill			34,351
Total assets acquired			47,751
Deferred tax liabilities assumed			(3,170)
Total			$ 44,581

Business Acquisition - Summar_3

Business Acquisition - Summary of Components of Identifiable Intangible Assets Acquired and Their Estimated Useful Lives (Details) - Re:infer $ in Thousands	Jul. 29, 2022 USD ($)
Business Acquisition [Line Items]
Fair Value	$ 13,100
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 10,000
Estimated Useful Life	5 years
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 3,100
Estimated Useful Life	3 years

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 37,878	$ 38,194
Accumulated Amortization	(21,418)	(15,184)
Intangible Assets, Net	16,460	23,010
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,241	28,517
Accumulated Amortization	(15,206)	(11,095)
Intangible Assets, Net	$ 13,035	$ 17,422
Weighted-Average Remaining Useful Life (in years)	3 years	3 years 6 months
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,135	$ 8,174
Accumulated Amortization	(5,577)	(3,601)
Intangible Assets, Net	$ 2,558	$ 4,573
Weighted-Average Remaining Useful Life (in years)	1 year 4 months 24 days	2 years
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 271	$ 272
Accumulated Amortization	(257)	(233)
Intangible Assets, Net	$ 14	$ 39
Weighted-Average Remaining Useful Life (in years)	4 months 24 days	1 year 2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(378)	(255)
Intangible Assets, Net	$ 853	$ 976
Weighted-Average Remaining Useful Life (in years)	7 years 2 months 12 days	7 years 8 months 12 days

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 2.1	$ 2.1	$ 6.4	$ 4.8

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2024	$ 2,123
2025	6,538
2026	4,004
2027	2,369
2028	1,123
Thereafter	303
Intangible Assets, Net	$ 16,460	$ 23,010

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 88,010
Effect of foreign currency translation	(717)
Ending Balance	$ 87,293

Operating Leases - Additional I

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 500
Current operating lease liabilities	$ 6,905	$ 6,997
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	14 years

Operating Leases - Summary of L

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Operating lease cost	$ 3,364	$ 3,060	$ 9,663	$ 8,555
Short-term lease cost	1,225	1,509	3,845	4,552
Variable lease cost	493	362	1,639	885
Sublease income	(426)	(532)	(1,491)	(1,597)
Total	$ 4,656	$ 4,399	$ 13,656	$ 12,395

Operating Leases - Weighted Ave

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Oct. 31, 2023	Jan. 31, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	11 years 2 months 12 days	12 years 1 month 6 days
Weighted-average discount rate (as a percent)	7%	7%

Operating Leases - Summary of F

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2024	$ 1,849
2025	12,284
2026	10,173
2027	9,432
2028	8,748
Thereafter	49,931
Total operating lease payments	92,417
Less: imputed interest	(27,825)
Total operating lease liabilities	$ 64,592

Operating Leases - Supplemental

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 3,486	$ 1,721	$ 9,646	$ 5,278
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 4,139	$ 5,769	$ 8,820	$ 8,659

Condensed Consolidated Balanc_5

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 65,755	$ 67,794
Other current assets	25,469	26,356
Prepaid expenses and other current assets	$ 91,224	$ 94,150

Condensed Consolidated Balanc_6

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 57,308	$ 56,976
Less: accumulated depreciation	(34,804)	(27,931)
Property and equipment, net	22,504	29,045
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	28,164	28,450
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	21,860	19,622
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,751	6,485
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 533	$ 2,419

Condensed Consolidated Balanc_7

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.7	$ 2.2	$ 8.5	$ 6

Condensed Consolidated Balanc_8

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 25,079	$ 19,411
Withholding tax from employee equity transactions	6,950	3,772
Employee stock purchase plan withholdings	8,217	3,365
Payroll taxes and other benefits payable	6,722	7,644
Income tax payable	12,774	8,750
Value-added taxes payable	4,342	6,381
Operating lease liabilities, current	6,905	6,997
Deferred consideration for business acquisition, current	5,570	5,863
Payable for marketable securities purchase	9,747	3,588
Other	21,708	10,874
Accrued expenses and other current liabilities	$ 108,014	$ 76,645

Credit Facility (Details)

Credit Facility (Details)	Oct. 30, 2020 USD ($)
Senior Secured Credit Facility | HSBC Ventures USA Inc., Silicon Valley Bank, Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit agreement	$ 200,000,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023	Nov. 10, 2022	Jun. 24, 2022
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 3,200		$ 3,200		$ 4,300
Defined contribution plan, contribution cost	3,300	$ 2,700	12,400	$ 11,400
Litigation Matters
Restructuring Cost and Reserve [Line Items]
Loss contingency accrual	0		0
Product Liability Contingencies
Restructuring Cost and Reserve [Line Items]
Loss contingency accrual	$ 0		0
Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Expected percentage reduction of global workforce						6%	5%
Restructuring costs incurred			$ 2,631

Commitments and Contingencies_2

Commitments and Contingencies - Accrued Restructuring Costs (Details) - Employee Termination Benefits $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Accrued restructuring costs, beginning balance	$ 3,889
Restructuring costs incurred	2,631
Amount paid	(6,072)
Accrued restructuring costs, ending balance	$ 448

Commitments and Contingencies_3

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2024	$ 11,164
2025	91,225
2026	64,667
2027	21,679
2028	8,245
Thereafter	0
Total	$ 196,980

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands	1 Months Ended	3 Months Ended			9 Months Ended
	Nov. 28, 2023	Oct. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Sep. 01, 2023
Class of Stock [Line Items]
Charitable contribution recorded as expense					$ 4,215,000	$ 5,499,000
Common Stock | Class A Common Stock
Class of Stock [Line Items]
Repurchase authorized							$ 500,000,000
Repurchased of common shares (in shares)		3,200			3,200
Average price of common shares (in dollar per share)		$ 16.26			$ 16.26
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)		2,800			2,800
Charitable donation of Class A common stock (in shares)			281	300	300
Common Stock | Class A Common Stock | Subsequent Event
Class of Stock [Line Items]
Repurchased of common shares (in shares)	1,700
Average price of common shares (in dollar per share)	$ 17.38

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Changes In Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,983,366	$ 1,955,537	$ 1,920,158	$ 1,849,549	$ 1,880,194	$ 1,921,917	$ 1,920,158	$ 1,921,917
Other comprehensive (loss) income, net of tax	(8,348)	1,432	2,462	(4,197)	709	(458)	(4,454)	(3,946)
Ending balance	1,961,213	1,983,366	1,955,537	1,859,824	1,849,549	1,880,194	1,961,213	1,859,824
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	11,506	10,074	7,612	11,150	10,441	10,899	7,612	10,899
Other comprehensive (loss) income, net of tax	(8,348)	1,432	2,462	(4,197)	709	(458)
Ending balance	3,158	$ 11,506	10,074	6,953	$ 11,150	10,441	3,158	6,953
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			8,231			11,234	8,231	11,234
Other comprehensive (loss) income, net of tax							(4,713)	(3,321)
Ending balance	3,518			7,913			3,518	7,913
Unrealized Gain (Loss) on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ (619)			$ (335)	(619)	(335)
Other comprehensive (loss) income, net of tax							259	(625)
Ending balance	$ (360)			$ (960)			$ (360)	$ (960)

Equity Incentive Plans and St_3

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		1 Months Ended			3 Months Ended	9 Months Ended
	Jul. 29, 2022	Jul. 31, 2023	Apr. 30, 2021	Sep. 30, 2020	Jul. 31, 2022	Oct. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)						$ 16.56
Intrinsic value of stock options exercised						$ 55,400
Cost not yet recognized for unvested options						$ 113,000
Restricted stock awards issued, value					$ 1
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued at closing subject to clawback provisions (in shares)	400
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						2 years 3 months 18 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						2 years 4 months 24 days
Fair value of RSUs vested						$ 236,200
Unrecognized compensation expense						$ 612,600
Grant date fair value per share (in dollars per share)						$ 16.54
Granted (in shares)						17,615
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						10 months 24 days
Unrecognized compensation expense						$ 900
Restricted stock awards issued (in shares)				100
Grant date fair value per share (in dollars per share)				$ 33.22
Restricted stock awards issued, value				$ 4,000
Award vesting period				4 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value per share (in dollars per share)		$ 18.08
Granted (in shares)		100
Performance Shares | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percent)		0%
Performance Shares | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percent)		100%
Performance Shares | Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percent)		200%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)			15,500
Period of shares automatically increase			10 years
Percentage of total number of shares			1%
Number of shares authorized (in shares)						21,500
Weighted-average remaining period						1 month 6 days
Unrecognized compensation expense						$ 700
Shares purchased (in shares)						800
Purchase price (in dollars per share)						$ 11.19
Common Stock | Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period	3 years					1 year 9 months 18 days
Unrecognized compensation expense	$ 7,600					$ 4,500
Class A Common Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price			85%
Purchase price of common stock, purchase date, percent of market price			85%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase			10 years
Percentage of total number of shares			5%
2021 Stock Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)						173,700

Equity Incentive Plans and St_4

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares
Stock Options
Outstanding, beginning balance (in shares) | shares	13,898
Granted (in shares) | shares	2,763
Exercised (in shares) | shares	(3,559)
Forfeited (in shares) | shares	(361)
Outstanding, ending balance (in shares) | shares	12,741	13,898
Vested and exercisable, Number of Stock Options (in shares) | shares	6,252
Weighted-Average Exercise Price
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 3.32
Granted (in dollars per share) | $ / shares	0.10
Exercised (in dollars per share) | $ / shares	1.52
Forfeited (in dollars per share) | $ / shares	0.51
Outstanding, ending balance (in dollars per share) | $ / shares	3.20	$ 3.32
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share) | $ / shares	$ 3.68
Outstanding, Weighted-Average Remaining Contractual Life (years)	7 years 7 months 6 days	7 years 8 months 12 days
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 4 months 24 days
Outstanding, Aggregate Intrinsic Value | $	$ 158,811	$ 169,324
Vested and exercisable, Aggregate Intrinsic Value | $	$ 74,680

Equity Incentive Plans and St_5

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	9 Months Ended
	Oct. 31, 2023 $ / shares shares
RSUs
Unvested, beginning balance (in shares) | shares	36,785
Granted (in shares) | shares	17,615
Vested (in shares) | shares	(13,773)
Forfeited (in shares) | shares	(6,569)
Unvested, ending balance (in shares) | shares	34,058
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 22.48
Granted (in dollars per share) | $ / shares	16.54
Vested (in dollars per share) | $ / shares	20.47
Forfeited (in dollars per share) | $ / shares	23.46
Unvested, ending balance (in dollars per share) | $ / shares	$ 20.03

Equity Incentive Plans and St_6

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 95,880	$ 81,091	$ 283,025	$ 270,797
Cost of revenue | Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3,791	2,844	10,778	8,901
Cost of revenue | Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,764	2,557	8,546	8,959
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	37,760	30,763	109,890	117,410
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	30,604	23,435	88,448	73,559
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 20,961	$ 21,492	$ 65,363	$ 61,968

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Valuation Allowance [Line Items]
Provision for income taxes	$ 3,926	$ 1,182	$ 11,388	$ 10,061
Effective tax rate	(14.20%)	(2.10%)	(10.10%)	(3.50%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 2,300		$ 2,300
Liability pertaining to uncertain tax positions	1,500		1,500
Japan
Valuation Allowance [Line Items]
Deferred tax valuation allowance	$ 0		$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (31,537)	$ (60,361)	$ (31,901)	$ (57,724)	$ (120,378)	$ (122,561)	$ (123,799)	$ (300,663)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	567,036			550,164			562,651	546,087
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	567,036			550,164			562,651	546,087
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (26,951)			$ (49,073)			$ (105,657)	$ (255,266)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	484,583			467,711			480,198	463,634
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	484,583			467,711			480,198	463,634
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (4,586)			$ (8,651)			$ (18,142)	$ (45,397)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	82,453			82,453			82,453	82,453
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	82,453			82,453			82,453	82,453
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	51,158	46,301	53,093	44,575
Class A Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	36,911	31,022	38,137	29,307
Class A Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	13,207	13,812	13,764	13,913
Class A Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	52	104	56	355
Class A Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	714	936	762	851
Class A Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	274	427	374	149
Class B Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Related Party Transaction [Line Items]
Operating expenses	$ 331,820	$ 286,967	$ 940,060	$ 920,808
Related Party
Related Party Transaction [Line Items]
Operating expenses	$ 0	$ 0	$ 0	$ 1,900